altimmune glp 1 Altimmune, Inc. Announces Presentation of IMPACT Phase 2b Study Results at EASL Congress 2026, Highlighting Efficacy and Safety Data for Pemvidutide in MASH 9 Companies Developing Next-Generation GLP-1

altimmune glp 1

altimmune glp 1 Altimmune, Inc. Announces Presentation of IMPACT Phase 2b Study Results at EASL Congress 2026, Highlighting Efficacy and Safety Data for Pemvidutide in MASH 9 Companies Developing Next-Generation GLP-1

Name: altimmune glp 1 Altimmune, Inc. Announces Presentation of IMPACT Phase 2b Study Results at EASL Congress 2026, Highlighting Efficacy and Safety Data for Pemvidutide in MASH 9 Companies Developing Next-Generation GLP-1
Brand: inesschwebach.de
SKU: 34581188747
Price: 20.32 USD
Availability: InStock
Rating: 4.4590000000000005 (16 reviews)

SKU: 34581188747

4.5

USD20.32 USD60.32

Pay in 4 interest-free payments of $5.08 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 29 - Nov 3

Description

The good news: With the right support you can feel like yourself again

Fisher has a financial interest in Soltego, Inc., a company developing SIK inhibitors for topical skin darkening treatments that might be used for a broad set of human applications